Your browser doesn't support javascript.
loading
Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan.
Ko, Ko; Takahashi, Kazuaki; Nagashima, Shintaro; E, Bunthen; Ouoba, Serge; Hussain, Md Razeen Ashraf; Akita, Tomoyuki; Sugiyama, Aya; Sakaguchi, Takemasa; Tahara, Hidetoshi; Ohge, Hiroki; Ohdan, Hideki; Kubo, Tatsuhiko; Ishikawa, Nobuhisa; Takafuta, Toshiro; Fujii, Yoshiki; Mimori, Michi; Okada, Fumie; Kishita, Eisaku; Ariyoshi, Kunie; Kuwabara, Masao; Tanaka, Junko.
Afiliación
  • Ko K; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Takahashi K; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Nagashima S; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • E B; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Ouoba S; Payment Certification Agency, Ministry of Health, Phnom Penh, Cambodia.
  • Hussain MRA; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Akita T; Unité de Recherche Clinique de Nanoro (URCN), Institut de Recherche en Science de la Santé (IRSS), Nanoro, Burkina Faso.
  • Sugiyama A; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Sakaguchi T; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Tahara H; Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Ohge H; Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Ohdan H; Department of Cellular and Molecular Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Kubo T; Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan.
  • Ishikawa N; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Takafuta T; Department of Public Health and Health Policy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Fujii Y; Department of Respiratory Medicine, Hiroshima Prefectural Hospital, Hiroshima, Japan.
  • Mimori M; Hiroshima City Funairi Citizens Hospital, Hiroshima, Japan.
  • Okada F; Hiroshima City Institute of Public Health, Hiroshima, Japan.
  • Kishita E; Hiroshima City Health and Welfare Bureau, Hiroshima, Japan.
  • Ariyoshi K; Hiroshima Prefectural Health and Welfare Bureau, Hiroshima, Japan.
  • Kuwabara M; Hiroshima Prefectural Health and Welfare Bureau, Hiroshima, Japan.
  • Tanaka J; Hirishima Prefectural Technology Research Institute Health and Environment Center, Hiroshima, Japan.
Sci Rep ; 12(1): 2419, 2022 02 14.
Article en En | MEDLINE | ID: mdl-35165301
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tamizaje Masivo / Análisis de Secuencia de ADN / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tamizaje Masivo / Análisis de Secuencia de ADN / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Japón